Furthermore, in vitro and in vivo analyses using glioblastoma, melanoma, and HNSQ cell lines supported the anti-tumor effects of SLC27A2, suggesting that FATP2 can induce ferroptosis in several cancers, including EBV-infected lymphoma. This evidence concerns the gene SLC27A2 and melanoma.